27 results
424B5
ITCI
Intra-Cellular Therapies Inc
5 Jan 22
Prospectus supplement for primary offering
4:51pm
, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from
424B5
ITCI
Intra-Cellular Therapies Inc
3 Jan 22
Prospectus supplement for primary offering
5:30pm
for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example
424B5
q545j63px7i
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
33e5 jso4n571w
9 Sep 20
Prospectus supplement for primary offering
4:40pm
424B5
lr1zy7gkapf 1hi87
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
vycthd
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
vlyqtzdvvg
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
ft5nyui2 jxcq6
6 Jan 20
Automatic shelf registration
4:02pm
424B5
lhr 5gjeheghehix
6 Mar 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.3
ekydv9yfk i8ew48k6k7
4 Mar 15
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
424B5
huvvmy 3bcuq
4 Mar 15
Prospectus supplement for primary offering
12:00am